Showing posts with label leprosy. Show all posts
Showing posts with label leprosy. Show all posts

Thursday, February 7, 2019

Why universal medical insurance is on the way




Dr KK Aggarwal

Universal health care (universal health coverage, universal coverage, universal care, or socialized health care) is a national health care system that provides health care and financial protection to all citizens of a country. It provides a specified package of benefits to all members of a society with an aim of providing financial risk protection, improved access to health services, and improved health outcomes. The health care does not cover everything for everyone.

The critical components are

·         Who is covered?
·         What medical services are covered?
·         How much of the cost is covered?

As part of Sustainable Development Goals (SDGs), United Nations member states have agreed to work toward worldwide universal health coverage by 2030.

In India with a population of 133.92 crores, Ayushman Bharat will cover 50% of the population (40% or 50 crore people in conventional scheme + additional 10 % people with income less than 8 lakh per annum). For them insurance premium will be paid and shared by the central government (60%) and state government (40%) from the central and state taxes collected from the people.

Another 32% of the population is medically covered by Employee State Insurance (ESI) (8% employees + 10% unrecognised sector); Railway (9%); Defence (1.1%), state health insurance schemes (1%), Municipal corporations (1%); CGHS (36,67,795 people) and PSUs (0.75 crore family beneficiaries) [1%] another 1% is covered through private companies (corporates).

The remaining 18% of the population comprises people with annual income of more than 8 lakh per annum who can easily afford individual private insurance.

To make universal coverage possible the options include:

·         The government should make it mandatory to have insurance for those not covered by any government, PSU or NGO scheme.
·         Like ESI, it should be mandatory to have the employee insured by the employer as part of his or her salary package.
·         Around 41% of the population has some life cover, which should provide some medical cover.
·         Any individual with salary up to Rs 21,000 per month is entitled for ESI insurance; this should also be allowed for all those will salaries less than Rs 8 lakh per annum.
·         Ayushman Bharat provides coverage for up to 5 lakh for the family. However, most packages are capped, and the average expenditure is only Rs 18000/- per admission. Till today in the last 4 months, only 10 lakh people have been treated with an expenditure of only Rs 1800 crores (@ Rs 18000/- per person). At this rate, the annual expenditure will be only Rs 7200 crore (shared by center and state in a ratio of 60:40). This amounts to very little for the country.
·         If required, the government can cover additional 18% of the population also. With this the government will be able to ensure coverage for 100% population and provide general ward basic and emergent treatment to all admissions

For this to happen the government must also ensure affordable health care by implementing one company - one drug - one price policy; incentives to open Ayushman-only hospitals by small healthcare doctor-owned setups and capping the prices of National List of Essential Drugs, devices, reagents, investigations, equipment and disposables.

The government should also make it mandatory for all establishments to provide 10% beds for Ayushman patients.

The cost of providing universal national immunization; “nationalizing” diseases and health issues of national importance like TB, AMR, Leprosy, cancer, dialysis and providing free treatments to all should continue via the national health annual budget, which itself should be raised by another 25% to be made around Rs 75000 crores. This budget should cover the proposed 1.5 lakh wellness centers.

To further improve the health budget, the total budget for environmental pollution (air, water, earth); budget for women and child health, mid-day school meal, Swachh Bharat, road safety, pharma sector, food industry etc. should be merged with an aim to reduce the disease burden.

The government should provide coverage only for general ward treatment. There will still be enough business left for private and national insurance companies for additional insurance coverage for private wards and diseases not covered under Ayushman Bharat.


Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of Medical Associations in Asia and Oceania   (CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of India
Past National President IMA

Tuesday, January 29, 2019

Will leprosy be eliminated from the country this year?


Leprosy was eliminated from India in 2005, yet leprosy continues to be prevalent in the country as is evident from the NLEP Annual data for the year 2017-18 on the status of leprosy in India. Elimination means a prevalence rate of less than 1 case per 10,000 population at national level.

As on March 2018, at least seven states had more than 5000 cases. With 14,338 cases, Bihar had the highest no. of cases followed by UP with 12, 583 cases; Maharashtra (9836 cases), West Bengal (9175 cases), Chattisgarh (6499 cases), Odisha (6325 cases) came next (Source: National Leprosy Eradication Programme website).

Three states still have a prevalence rate exceeding the required less than 1 case per 10,000 population: Chattisgarh (2.25), Bihar (1.18) and Odisha (1.38).

Leprosy is now being detected from parts of the country not known to be prevalent for leprosy. Also, cases of multibacillary leprosy(>5 lesions with involvement of≥2 nerves) as well as cases with deformities are being detected indicating advanced stage of the disease. This means late diagnosis or failure of early leprosy detection. Early detection is crucial to its elimination.

The special Leprosy Case Detection 15-day Campaign for early detection of leprosy cases in high endemic districts conducted in 2016 had identified more than 32,000 confirmed cases.

Leprosy: At a glance

·         Leprosy, also known Hansen's disease is an infectious disease caused by mycobacteria of the Mycobacterium leprae complex that involve the skin and peripheral nerves. 
·         Early diagnosis and a full course of treatment are critical for preventing lifelong neuropathy and disability. 
·         Leprosy is probably spread by the respiratory route. In the US, it is also a zoonosis; contact with armadillos has been documented in some cases. 
·         Leprosy is classified using the following categories: tuberculoid (TT), borderline tuberculoid (BT), mid-borderline (BB), borderline lepromatous (BL), lepromatous (LL), and indeterminate (I). 
·         Early physical exam findings include hypopigmented/reddish skin patches, diminished/loss of sensation in involved areas, paresthesias, painless wounds or burns and tender, enlarged peripheral nerves. 
·         The diagnosis is established when at least one of these physical findings is present and a skin biopsy obtained from the leading edge of the skin lesion confirms the presence of acid-fast bacilli in a cutaneous nerve. 


Achieving and maintaining elimination status of Leprosy by 2018 was one of the targets under the National Health Policy 2017 (Source: Press Information Bureau, March 23, 2018).

A nationwide post-exposure prophylaxis was also launched last year with single-dose rifampicin for all contacts of leprosy cases detected as per the 2018 WHO guidelines on the diagnosis, treatment & prevention of leprosy.

The WHO guidelines recommend the “use of single-dose rifampicin (SDR) as preventive treatment for adult and child (2 years of age and above) contacts of leprosy patients, after excluding leprosy and tuberculosis (TB) disease and in the absence of other contraindications”.

Now the Govt. has planned elimination of leprosy under Sparsh leprosy Awareness Campaign (SLEC) by 2nd Oct, 2019 to commemorate the 150th Birth Anniversary of Mahatma Gandhi vide a letter from Dr Anil Kumar, Deputy Director General (Leprosy) DO No. X-11016/07/2015-Lep, dated 14th Sept. 2018 (Source: National Leprosy Eradication Programme website).

Will leprosy be eliminated from the country this year?

We hope for the best, but this target appears elusive for now.


Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of Medical Associations in Asia and Oceania   (CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of India
Past National President IMA